Congress 110, Senate vote: Vote 154: S 1082
Vote description: Grassley Amdt. No. 1039; To clarify the authority of the Office of Surveillance and Epidemiology with respect to postmarket drug safety pursuant to recommendations by the Institute of Medicine.
Result: Rejected, 46-47, with 7 not voting.
Richard Shelby voted No.